year
ago
fascin
discoveri
made
differ
tissu
sampl
place
anterior
chamber
dog
rabbit
observ
month
surprisingli
induc
intraocular
inflamm
limit
tissu
sampl
reject
known
occur
part
bodi
time
eye
one
first
site
immun
privileg
recogn
today
know
eye
uniqu
complex
organ
develop
multipl
mechan
protect
frivol
immunolog
attack
inflamm
order
maintain
delic
structur
function
bloodocular
barrier
system
form
bloodaqu
barrier
inner
outer
bloodretin
barrier
restrict
limit
passag
ion
protein
maintain
homeostasi
keep
tissuespecif
antigen
sequestr
furthermor
mani
activ
factor
discov
eye
contribut
downregulatori
immun
environ
die
bloodocular
barrier
die
mechan
depend
proper
function
central
preserv
immun
privileg
eye
immun
privileg
serv
well
curb
excess
inflamm
preserv
function
howev
privileg
may
lost
certain
condit
situat
result
retin
autoimmun
ocular
inflamm
dysfunct
inner
bloodretin
barrier
initi
diabet
retinopathi
breakdown
bloodretin
barrier
also
found
cystoid
macular
edema
loss
die
essenti
mani
form
uveiti
probabl
develop
agerel
macular
degener
amd
long
time
retin
autoimmun
perceiv
pathogen
activ
suppress
retin
immun
presum
necessari
maintain
health
eye
howev
studi
shown
presenc
retin
autoantibodi
normal
control
constitut
express
proinflammatori
ligand
found
normal
retina
high
concentr
b
kim
pillai
z
li
unpublish
data
moreov
anim
optic
nerv
injuri
studi
reveal
possibl
benefici
role
retin
autoimmun
control
collater
damag
retin
ganglion
cell
thu
retin
autoimmun
view
doubleedg
sword
protect
destruct
effect
understand
retin
autoimmun
first
understand
basic
concept
immunolog
immunolog
compon
work
maintain
eye
immun
privileg
robert
katamay
robert
b
nussenblatt
two
system
immun
innat
adapt
coexist
keep
pathogen
innat
immun
phlyogenet
earlier
nonspecif
immedi
respons
first
immun
respons
mount
invad
pathogen
key
compon
innat
immun
cadr
leukocyt
plasma
protein
capabl
detect
destroy
pathogen
leukocyt
includ
polymorphonuclear
cell
monocyt
macrophag
natur
killer
nk
cell
eosinophil
basophil
plasma
protein
belong
famili
complement
cascad
clot
cascad
acutephas
reactant
contrast
adapt
immun
name
impli
antigenspecif
adapt
transfer
cardin
featur
like
immunolog
memori
toler
adapt
immun
evolv
develop
novel
molecul
like
antibodi
tcell
receptor
tcr
come
almost
limitless
varieti
recogn
molecul
biolog
interest
includ
self
nonself
molecul
develop
absenc
exogen
stimul
uniqu
configur
confer
specif
antigen
recognit
key
cellular
compon
adapt
immun
b
lymphocyt
possess
uniqu
receptor
recogn
billion
differ
antigen
epitop
clone
lymphocyt
express
molecularli
ident
receptor
surfac
henc
order
recogn
billion
differ
epitop
billion
uniqu
lymphocyt
upon
matur
thymu
cell
bone
marrow
b
cell
cell
remain
quiescent
cell
cycl
encount
complementari
antigen
suffici
affin
receptor
bind
receptor
presenc
appropri
costimul
initi
event
trigger
immun
respons
target
elimin
complementari
molecul
molecul
pathogenderiv
activ
lead
elimin
pathogen
molecul
selfderiv
activ
potenti
lead
autoimmun
tissu
injuri
diseas
destruct
host
tissu
activ
naiv
lymphocyt
result
emerg
clone
lymphocyt
prolifer
uniqu
receptor
recogn
one
epitop
incit
antigen
cytokin
environ
activ
naiv
cell
respons
differenti
three
major
type
section
basic
scienc
translat
therapi
array
cytokin
includ
granulocytemacrophag
colonystimul
factor
cytokin
serv
growth
stimul
factor
lymphocyt
apc
henc
amplifi
prolifer
process
addit
also
promot
differenti
lymphocyt
matur
cytotox
lymphoct
ctl
recogn
antigenderiv
peptid
present
class
mhc
molecul
upon
activ
ctl
function
effector
lyse
target
cell
also
produc
proinflammatori
cytokin
especi
cytokin
product
cell
also
promot
activ
differenti
b
lymphocyt
stimul
b
cell
produc
complementfix
immunoglobulin
g
igg
antibodi
result
product
noncomplementfix
igg
ige
iga
antibodi
final
product
central
process
lymphoid
tissu
immun
effector
cell
b
cell
receptor
specif
incit
antigen
transport
predominantli
via
hematogen
rout
site
incit
antigen
execut
effector
function
therebi
complet
effer
loop
immun
respons
target
site
site
infect
inflamm
vessel
leaki
vascular
endotheli
cell
display
ligand
bind
receptor
immun
cell
chemokin
secret
local
inflammatori
cell
serv
attract
immun
effector
cell
site
engag
activ
b
cell
direct
activ
cell
still
need
apc
antigen
recognit
activ
cell
secret
cytokin
tumor
necrosi
factor
tnf
turn
attract
recruit
cell
innat
immun
system
monocyt
macrophag
nk
cell
site
effect
actual
destruct
antigen
pathogen
gener
cytotox
product
phagocytosi
pathogen
b
cell
secret
antibodi
specif
antigen
result
direct
killinglysi
target
also
recruit
polymorphonuclear
cell
via
complement
activ
complement
activ
product
respect
way
adapt
immun
system
serv
direct
innat
immun
system
compon
target
incit
antigen
pathogen
immun
system
regul
part
immun
respons
loop
ie
affer
limb
central
process
effer
limb
regul
autoimmun
respons
via
follow
mechan
central
toler
clonal
delet
peripher
toler
clonal
anergi
tcell
suppress
immun
deviat
immunolog
ignor
antigen
sequestr
sinc
genom
capabl
gener
selfand
nonselfrecogn
antibodi
tcr
mechan
must
place
contain
prevent
activ
selfreact
cell
lymphocyt
develop
b
cell
receptor
recogn
self
molecul
high
affin
clonal
delet
via
apoptosi
central
toler
howev
process
foolproof
autoreact
b
cell
peripheri
exist
even
normal
individu
mani
tissuespecif
antigen
like
eyerestrict
molecul
may
express
thymu
cell
may
escap
select
process
central
toler
mechan
thymu
without
encount
specif
self
antigen
henc
potenti
induct
express
autoimmun
still
exist
mechan
contain
autoreact
immun
effector
cell
interferon
ifn
lead
cell
product
interleukin
il
respons
product
cell
clone
becom
memori
cell
respons
enhanc
immun
respons
antigen
reencount
rest
secret
cytokin
target
macrophag
cell
mediat
cellular
immun
contrast
stimul
b
cell
prolifer
antibodi
product
mediat
humor
immun
recent
discov
famili
helper
cell
capabl
produc
seem
need
human
differenti
play
import
role
combat
variou
bacteri
fungal
speci
produc
contrast
larg
amount
found
autoimmun
diseas
like
uveiti
multipl
sclerosi
rheumatoid
arthriti
immun
accessori
cell
includ
innat
immun
system
activ
elimin
pathogen
way
adapt
immun
serv
enhanc
immun
protect
bettercoordin
specif
attack
use
innat
immun
mechan
within
genom
lie
abil
creat
antibodi
tcr
antigen
bind
self
antigen
high
affin
henc
threat
autoimmun
inborn
regul
crucial
abil
distinguish
foreign
self
abil
regul
autoimmun
critic
surviv
immun
respons
seen
analog
neural
reflex
arc
affer
limb
central
process
effer
limb
immun
affer
limb
antigen
captur
process
transport
final
present
lymphocyt
naiv
lymphocyt
activ
organ
lymph
tissu
secondari
lymphoid
organ
lymph
node
spleen
tonsil
peyer
patch
need
special
cell
execut
immun
affer
limb
cell
profession
antigenpres
cell
apc
dendrit
cell
macrophag
bone
marrowderiv
apc
function
serv
captur
antigen
phagocytosi
endocytosi
process
antigen
present
process
antigen
conjunct
special
major
histocompat
complex
mhc
molecul
cell
surfac
addit
apc
provid
necessari
costimul
need
lymphocyt
activ
upregul
array
surfac
molecul
intercellular
adhes
lymphocyt
functionassoci
function
ligand
receptor
express
lymphocyt
also
secret
cytokin
serv
similar
costimul
function
costimul
requir
second
signal
full
activ
lymphocyt
independ
first
signal
antigen
lymphocyt
receptor
engag
differ
antigen
present
b
lymphocyt
b
lymphocyt
receptor
surfacebound
antibodi
engag
naiv
antigen
directli
tcr
recogn
peptid
fragment
present
special
surfac
molecul
mhc
class
ii
mhc
class
present
cell
present
peptid
deriv
protein
degrad
cytoplasm
intracellular
antigen
viral
intracellular
microb
product
mhc
class
ii
molecul
present
apc
lymphocyt
present
peptid
phagocyt
vesicl
extracellular
antigen
microenviron
upon
activ
first
cell
respond
cell
specif
present
peptid
mhc
class
ii
molecul
apc
lymphocyt
prolifer
secret
result
hyperactiv
cell
sever
autoimmun
diseas
natur
induc
treg
maintain
peripher
toler
modifi
function
cell
popul
either
directli
tcell
tcell
interact
indirectli
apc
henc
crucial
maintain
immun
homeostasi
control
autoimmun
order
keep
immun
system
healthi
end
centuri
german
bacteriologist
immunologist
paul
ehrlich
experi
stain
tissu
anim
model
inject
dye
bloodstream
almost
tissu
color
intens
howev
brain
remain
unstain
year
later
one
ehrlich
student
edwin
goldmann
perform
experi
way
around
inject
dye
cerebrospin
fluid
time
brain
becam
stain
rest
bodi
remain
dyefre
goldmann
correctli
conclud
restrict
barrier
mechan
inhibit
passag
solubl
two
compart
blood
cerebrospin
fluid
year
schnaudigel
found
similar
barrier
trypan
blue
retina
rabbit
today
know
eye
consist
sever
anatom
structur
limit
flux
blood
part
eye
bloodocular
barrier
repres
two
main
compon
bloodaqu
barrier
bloodretin
barrier
bloodaqu
barrier
form
nonpig
layer
ciliari
bodi
epithelium
endothelium
irid
capillari
bloodretin
barrier
locat
two
level
inner
barrier
nonfenestr
capillari
retin
vessel
wherea
outer
barrier
tight
junction
rpe
enabl
high
degre
control
fluid
permeabl
limit
passag
ion
enabl
eye
maintain
homeostasi
aqueou
humor
retina
barrier
also
keep
small
larg
molecul
like
drug
enter
eye
special
hydrophil
substanc
show
low
permeabl
across
bloodocular
barrier
furthermor
barrier
essenti
immunolog
function
sequestr
tissuespecif
antigen
crucial
preserv
immun
privileg
eye
therefor
avoid
intraocular
inflamm
hand
inflamm
caus
breakdown
bloodretin
barrier
lead
autoimmun
inflamm
allow
drug
molecul
penetr
eye
consid
essenti
function
surpris
mani
common
eye
diseas
directli
associ
alter
bloodocular
barrier
initi
disord
caus
nonprolif
prolif
diabet
retinopathi
chronic
hyperglycemia
lead
retin
hypoxia
compensatori
mechan
like
vasodilat
regulatori
attempt
increas
retin
blood
flow
exhaust
autoregul
disrupt
endotheli
tight
junction
retin
vasculatur
occur
furthermor
chronic
hyperglycemia
seem
abl
induc
hypoxiamedi
express
growth
factor
cytokin
retin
endothelium
insulinlik
growth
cell
crucial
prevent
autoimmun
evid
peripher
toler
found
phase
immun
respons
ie
affer
limb
central
process
effer
limb
affer
limb
depend
heavili
function
properti
apc
offer
mani
opportun
modul
first
antigen
sequestr
prevent
contact
apc
physic
barrier
render
apc
incap
antigen
captur
microenviron
sequestr
second
abil
apc
degrad
process
express
antigen
inhibit
third
antigenbear
apc
may
prevent
migrat
lymphoid
tissu
lastli
abil
apc
gener
costimulatori
signal
inhibit
differ
costimulatori
signal
may
produc
immun
deviat
regul
apc
function
seen
form
immunolog
ignor
reactiv
autoimmun
cell
present
never
opportun
encount
antigen
proper
immunogen
form
due
defici
antigen
present
central
process
phase
immun
respons
two
signal
requir
full
activ
lymphocyt
absenc
costimul
presenc
antigenspecif
stimul
render
cell
unrespons
antigen
stimul
even
presenc
costimulatori
signal
anergi
hand
much
costimul
presenc
high
antigen
dose
may
lead
profound
cell
activ
apoptosi
mechan
result
toler
also
known
apc
certain
immuneprivileg
site
eye
apc
gut
process
oral
ingest
antigen
may
caus
immun
cell
develop
immunoregulatori
cell
like
cell
transform
growth
secret
cell
cell
common
adapt
regulatori
receiv
suppress
potenti
follow
specif
antigen
stimul
particular
cytokin
milieu
effer
limb
immun
regul
occur
via
target
level
antigenspecif
immun
effector
cell
one
mechan
would
fa
ligand
fasinduc
apoptosi
lymphocyt
immunereact
lymphocyt
express
receptor
fa
receptor
encount
fa
ligand
express
immunoprivileg
eye
tissu
cornea
retina
immun
cell
undergo
apoptosi
molecular
mechan
product
immun
accessori
cell
cell
retin
pigment
epitheli
rpe
cell
antigen
encount
also
result
apoptosi
therebi
delet
immunereact
cell
similar
central
process
effector
cell
need
costimulatori
signal
activ
express
inappropri
costimulatori
signal
apc
lead
anergi
reprogram
lymphocyt
immunoregulatori
cell
secret
immunosuppress
cytokin
therebi
suppress
autoimmun
import
regul
immun
respons
forkhead
box
protein
regulatori
cell
treg
two
group
treg
human
natur
occur
treg
induc
treg
natur
treg
development
determin
thymu
distinct
tcell
subpopul
special
suppress
function
distinguish
induc
treg
demethyl
promot
region
seem
act
repressor
transcript
regul
tcell
activ
dysfunct
basic
scienc
translat
therapi
va
cular
endotheli
growth
factora
lead
leukocyt
adhes
endotheli
cell
injuri
increas
permeabl
endotheli
cell
final
angiogenesi
result
plasma
leakag
inner
bloodretin
barrier
may
caus
diabet
macular
edema
consecut
vision
loss
cystoid
macular
edema
major
reason
vision
loss
variou
ocular
diseas
differ
condit
trauma
inflamm
vascular
degener
lead
increas
permeabl
bloodretin
barrier
inner
outer
ple
xiform
layer
retina
act
diffus
barrier
continu
fluid
distribut
therefor
breakdown
inner
bloodretin
barrier
caus
cyst
mainli
inner
nuclear
layer
wherea
serum
leakag
outer
bloodretin
barrier
pool
cystic
space
henl
fiber
layer
eye
recogn
immuneprivileg
site
year
medawar
demonstr
show
prolong
often
indefinit
surviv
organ
tissu
graft
anterior
chamber
eye
known
immun
privileg
dynam
process
immunoregulatori
mechan
combin
anatom
factor
maintain
vital
graft
privileg
site
privileg
organ
tissu
graft
variou
tissu
includ
allogen
skin
graft
thyroid
tissu
neuron
retin
tissu
allogen
tumor
cell
shown
surviv
anterior
chamber
eye
prolong
period
howev
privileg
influenc
immunogen
strength
antigen
express
cell
tumor
express
mhcencod
alloantigen
transient
extens
surviv
compar
express
weaker
transplant
antigen
although
studi
done
place
tissu
anterior
chamber
eye
number
studi
demonstr
similar
immun
privileg
allogen
tumor
cell
foreign
neuron
retin
tissu
rpe
place
vitreou
caviti
subretin
space
certain
eye
tissu
known
immuneprivileg
ie
demonstr
alter
immun
respons
less
reject
ocular
tissu
includ
cornea
rpe
probabl
retina
transplant
beneath
capsul
kidney
nonimmuneprivileg
site
cornea
demonstr
extend
surviv
compar
ocular
tissu
like
conjunctiva
passiv
factor
bloodretin
barrier
activ
factor
die
essenti
establish
maintain
ocular
immun
privileg
tabl
bloodretin
barrier
serv
keep
tissuespecif
antigen
sequestr
absenc
lymphat
retina
although
evid
antigen
may
still
abl
transport
lymph
node
tissu
drainag
via
hematogen
rout
may
alter
apc
function
also
reduc
express
mhc
class
ii
molecul
absenc
bone
marrowderiv
cell
function
within
tissu
apc
normal
retina
die
evolutionari
adapt
eye
protect
excess
inflamm
small
focu
inflamm
eye
far
greater
impact
similar
one
kidney
posterior
segment
seem
sever
activ
factor
help
keep
local
immunoenvironment
balanc
downregulatori
state
activ
factor
includ
downregulatori
effect
cell
celltocel
contact
lymphocyt
furthermor
mani
ocular
cell
affect
die
nk
cell
rpe
microglia
macrophag
well
cell
surfac
solubl
factor
ocular
microenviron
eg
ligand
hormon
vasoact
intestin
peptid
calcitonin
generel
peptid
macrophag
migrationinhibitori
factor
antagonist
free
cortisol
factor
contribut
activ
immunoregul
attempt
prevent
autoimmun
sever
find
patient
amd
eg
variant
cfh
tolllik
receptor
activ
macrophag
blood
autoantibodi
retin
compon
allow
consid
immunemedi
diseas
addit
mask
random
pilot
studi
indic
antiinflammatori
therapi
benefici
treat
wet
amd
associ
may
directli
relat
amd
rather
underli
die
weaken
bring
balanc
anteriorchamberassoci
immun
deviat
acaid
beststudi
immuneprivileg
phenomenon
eye
although
name
impli
anteriorchamb
phenomenon
much
inform
show
mechan
work
vitreou
subretin
space
therefor
understand
acaid
could
knowledg
retin
autoimmun
larg
number
bone
marrowderiv
apc
iri
trabecular
meshwork
ciliari
bodi
studi
demonstr
antigen
captur
anterior
chamber
apc
process
spleen
apc
reach
spleen
via
hematogen
rout
bypass
affer
lymphat
lymph
node
result
reduct
antigen
capac
activ
cellmedi
immun
mechan
function
apc
differ
transfer
apc
induc
acaid
rather
induc
convent
immun
respons
microenviron
eye
also
contain
factor
abl
reprogram
apc
convent
site
expos
eye
microenviron
secret
less
express
less
costimulatori
signal
tcell
activ
produc
matur
treat
apc
activ
naiv
cell
secret
trace
amount
spleen
critic
lymphoid
organ
induct
acaid
spleen
uniqu
popul
lymphocyt
secret
develop
immun
respons
upon
antigen
exposur
activ
bcell
respons
occur
upon
reexposur
antigen
adjuv
produc
isotyp
antibodi
instead
consist
respons
appear
concert
effort
deviat
immun
respons
usual
pathway
pathway
one
seen
allerg
respons
role
ligand
fa
ligand
still
unclear
tempt
specul
fa
ligand
act
caus
activ
immun
cell
apoptos
upon
engag
therebi
result
elimin
activ
immun
cell
one
would
expect
upregul
inflammatori
respons
fa
ligand
absent
eye
contrari
predict
fa
liganddefici
mice
develop
less
sever
inflamm
experiment
autoimmun
uveoretin
eau
wild
type
studi
use
fa
liganddefici
mice
also
reveal
acaid
depend
presenc
fa
ligand
mice
unabl
induc
acaid
henc
fasfa
ligand
interact
may
complex
induc
apoptosi
activ
immun
cell
initi
presum
although
activ
solubl
factor
aqueou
humor
inhibit
tcell
activ
vitro
decreas
abil
nk
cell
lyse
target
block
complement
activ
eye
left
defenseless
pathogen
still
retain
certain
immun
function
deter
pathogen
invas
antibodi
aqueou
capabl
neutral
virus
cytotox
cell
termin
differenti
bind
kill
target
cell
elsewher
bodi
sever
anim
model
autoimmun
posterior
uveiti
describ
tabl
eau
one
studi
model
sinc
develop
wacker
lipton
good
anim
model
human
ocular
autoimmun
eau
mostli
selflimit
requir
use
adjuv
diseas
induct
eau
model
instrument
elicit
immun
mechan
identif
pathogen
epitop
autoantigen
eye
anim
evalu
therapeut
strategi
clinic
relev
sever
retin
antigen
includ
santigen
arrestin
interphotoreceptor
retinoidbind
protein
irbp
rhodopsin
recoverin
phosducin
found
uveitogen
properti
immun
antigen
fragment
induc
ocular
inflamm
suscept
strain
guinea
pig
rat
mice
rabbit
monkey
diseas
induc
resembl
variou
human
uveit
condit
ocular
sarcoidosi
fig
vogtkoyanagiharada
diseas
sympathet
ophthalmia
diseas
fig
use
advanc
techniqu
novel
eye
autoantigen
identifi
uveal
autoantigen
coil
coil
domain
ankyrin
repeat
patient
vogtkoyanagiharada
diseas
unknown
retin
autoantigen
target
connect
cilium
region
photoreceptor
patient
macroglobulinemia
retin
dysfunct
similar
cancerassoci
retinopathi
much
understand
retin
autoantigen
deriv
eau
model
section
basic
scienc
translat
therapi
identifi
target
tcell
epitop
one
major
uveitogen
peptid
sequenc
fragment
speciesspecif
uveitogen
although
demonstr
uveitogen
properti
santigen
help
understand
uveiti
mechan
relev
human
uveiti
need
fulli
explor
santigen
also
implic
pathogenesi
uveiti
molecular
mimicri
shown
sever
exogen
baker
yeast
escherichia
coli
hepat
b
viru
streptococc
protein
moloney
murin
sarcoma
viru
baboon
endogen
viru
endogen
human
leukocyt
antigen
hla
bderiv
peptid
tropomyosin
antigen
share
sequenc
homolog
peptid
santigen
shown
uveitogen
eau
model
lymphocyt
anim
immun
peptid
crossreact
prolifer
stimul
peptid
deriv
exogen
endogen
antigen
antistreptococc
monoclon
antibodi
found
recogn
sever
uveitogen
peptid
use
santigen
irbp
peptid
deriv
protein
lesser
extent
rhodopsin
recoverin
phosducin
santigen
protein
also
refer
arrestin
one
antigen
commonli
use
induc
eau
first
identifi
solubl
fraction
retin
extract
first
autoretin
antigen
implic
pathogenesi
uveiti
sequenc
role
phototransduct
well
character
highli
conserv
protein
found
retin
photoreceptor
cell
pinealocyt
main
function
arrestin
block
interact
rhodopsin
gprotein
transducin
phototransduct
cascad
immun
suscept
anim
lewi
rat
mice
santigen
induc
predominantli
tcellmedi
inflammatori
respons
retina
uveal
tract
pineal
gland
six
peptid
fragment
santigen
identifi
uveitogen
six
region
santigen
bloodretin
barrier
immun
privileg
autoimmun
retinopathi
high
level
antirecoverin
antibodi
detect
patient
occult
cancer
retin
dysfunct
recent
autoantibodi
demonstr
induc
apoptosi
photoreceptor
support
pathogen
role
retin
autoimmun
phosducin
protein
cytosol
regul
gproteinmedi
signal
found
retina
also
nonretin
tissu
liver
lung
heart
brain
immun
phosducin
lewi
rat
produc
mild
moder
eau
character
late
onset
lowgrad
sever
predominantli
involv
posterior
segment
role
human
diseas
unclear
four
decad
work
eau
model
use
retin
autoantigen
pass
howev
still
unclear
whether
associ
occurr
eyespecif
autoantibodi
lymphocyt
prolifer
respons
clinic
diseas
exactli
role
pathogenesi
human
uveiti
potenti
immunemedi
diseas
like
amd
lymphocyt
reactiv
retin
antigen
demonstr
normal
individu
retin
diseas
normal
individu
presenc
circul
autoreact
cell
suggest
immunoregulatori
mechan
must
exist
prevent
retin
autoimmun
result
diseas
latter
tempt
hypothes
possibl
role
cell
induct
retin
autoimmun
humor
cellular
respons
santigen
irbp
investig
tlymphocyt
respons
santigen
irbp
peptid
deriv
patient
uveiti
investig
clinic
studi
increas
tlymphocyt
respons
report
patient
diseas
period
activ
ocular
inflamm
anoth
similar
studi
larg
proport
patient
lymphocyt
respond
stimul
santigen
irbp
sever
uveitogen
peptid
santigen
peptid
differ
report
cellular
respons
diseas
patient
without
uveiti
similar
cellular
respons
santigen
santigenderiv
peptid
peptid
g
uveitogen
peptid
deriv
irbp
report
patient
idiopath
uveiti
lymphocyt
prolifer
respons
peptid
span
entir
sequenc
santigen
investig
patient
uveiti
one
studi
half
patient
idiopath
uveiti
respond
least
one
peptid
wherea
respons
peptid
normal
control
peptid
fragment
found
elicit
lymphocyt
prolifer
fragment
irbp
santigen
studi
anoth
similar
studi
involv
patient
uveiti
patient
respond
irbp
santigen
also
respond
one
two
fragment
lesser
magnitud
suggest
fragment
probabl
primari
mediat
diseas
isol
santigenspecif
cell
eye
uveiti
patient
expand
antigenspecif
tcell
line
report
studi
evalu
oral
toler
feed
santigen
uveiti
patient
show
good
clinic
respons
santigen
provid
evid
immunolog
mimicri
self
exogen
antigen
infecti
agent
may
potenti
mechan
pathogenesi
uveiti
human
interphotoreceptor
retinoidbind
protein
irbp
use
induc
eau
mous
rat
major
protein
amino
acid
residu
interphotoreceptor
matrix
function
transport
retinoid
retina
rpe
similar
santigen
also
found
eye
pineal
gland
induct
eau
irbp
lead
diseas
locat
depend
dose
antigen
use
speci
anim
spectrum
diseas
rang
hyperacut
chronic
relaps
diseas
could
induc
inflamm
target
photoreceptor
layer
produc
histopatholog
similar
human
lesion
seen
uveiti
retin
vascul
granuloma
focal
serou
detach
loss
photoreceptor
format
subrp
infiltr
similar
dalenfuch
nodul
seen
patient
vogtkoyanagiharada
diseas
sympathet
ophthalmia
diseas
activ
show
two
peak
week
immun
simul
relaps
cours
human
uveiti
rel
long
durat
diseas
activ
murin
irbp
eau
model
make
good
model
evalu
therapeut
strategi
establish
diseas
immun
particul
fraction
retin
extract
fraction
p
shown
induc
eau
later
rhodopsin
identifi
uveitogen
antigen
fraction
p
rhodopsin
visual
pigment
rod
photoreceptor
cell
belong
larger
famili
gproteincoupl
receptor
membranebound
protein
compris
polypeptid
chain
opsin
coval
bound
chromophor
cisretin
function
rhodopsin
captur
photon
trigger
phototransduct
cascad
uveiti
induc
suscept
anim
guinea
pig
rabbit
rat
monkey
typic
retin
multifoc
destruct
photoreceptor
cell
show
dens
mononuclear
polymorphonuclear
cell
infiltr
retina
anterior
uvea
sever
diseas
three
distinct
immunopathogen
site
molecul
sequenc
extracellular
loop
vvi
uveitogen
compar
santigen
irbp
role
rhodopsin
autoantigen
human
diseas
still
unclear
studi
patient
normalpressur
glaucoma
demonstr
elev
antirhodopsin
antibodi
titer
indic
possibl
role
optic
neuropathi
observ
patient
recoverin
calciumbind
protein
present
photoreceptor
cell
function
calcium
sensor
regul
rhodopsin
phosphoryl
inhibit
rhodopsin
kinas
also
found
bipolar
cell
pinealocyt
certain
tumor
cell
function
nonphotoreceptor
cell
unknown
contain
rhodopsin
kinas
immun
lewi
rat
high
dose
recoverin
produc
eau
similar
sever
histolog
durat
retin
autoantigen
santigen
major
immunopathogen
epitop
sequenc
character
lewi
rat
identifi
autoantigen
paraneoplast
degen
diseas
retina
cancerassoci
section
basic
scienc
translat
therapi
cn
lead
degener
affect
axon
also
neighbor
axon
selfdestruct
compound
releas
degener
axon
microenviron
studi
reveal
autoreact
cell
direct
myelin
antigen
benefici
effect
cn
myelin
axon
mechan
crush
injuri
propos
neuroprotect
activ
exhibit
autoimmun
cell
may
physiolog
process
bodi
develop
cope
stress
condit
observ
seen
cn
could
extrapol
retina
support
find
studi
demonstr
vaccin
peptid
deriv
irbp
result
protect
retin
ganglion
cell
glutamateinduc
death
death
consequ
optic
nerv
injuri
appear
immun
system
protect
bodi
invad
pathogen
also
protect
toxic
substanc
releas
self
tissu
trauma
stress
therefor
autoreact
cell
induc
neuroprotect
induc
autoimmun
diseas
may
share
specif
phenotyp
indic
potenti
protect
destruct
time
final
outcom
depend
regul
correl
abil
manifest
autoimmun
respons
benefici
outcom
abil
resist
develop
autoimmun
diseas
anim
report
find
seem
clear
abil
protect
eye
inflamm
injuri
sole
depend
mechan
confer
immun
privileg
rather
precis
regul
autoimmun
role
infect
pathogenesi
eye
autoimmun
long
suspect
conclus
studi
demonstr
possibl
caus
relationship
infect
ocular
autoimmun
streptococcu
herpesviru
diseas
gramneg
bacteria
hla
uveiti
herpesvirus
serpigin
choroid
report
infect
exogen
trigger
inflamm
eye
entic
possibl
infect
link
pathogenesi
mani
autoimmun
diseas
rheumat
fever
inflammatori
bowel
diseas
sarcoidosi
antiretin
antibodi
serum
patient
toxoplasmosi
retinochoroid
antiretin
antirp
antibodi
murin
coronaviru
retinopathi
degener
report
report
provid
support
role
infect
retin
autoimmun
even
current
eau
model
anim
bacteriaderiv
product
like
mycobacteria
complet
freund
adjuv
lipopolysaccharid
pertussi
toxin
use
promot
develop
autoimmun
diseas
infect
could
possibl
play
similar
role
sensit
immun
system
eyerestrict
antigen
sequestr
express
low
level
immun
activ
threshold
mechan
involv
pathogenesi
uveiti
may
similar
adjuv
eau
includ
chang
bloodtissu
barrier
allow
infiltr
inflammatori
cell
promot
respons
stimulatori
effect
apc
enhanc
innat
immun
respons
hand
evid
immunolog
mimicri
may
play
role
pathogenesi
molecular
homolog
exist
certain
retin
autoantigen
peptid
deriv
microb
peptid
deriv
santigen
streptococc
cell
wall
peptid
yeast
patient
requir
less
immunosuppress
togeth
studi
provid
support
possibl
pathogen
role
retin
autoantigen
uveiti
although
eau
anim
uveiti
human
effector
respons
drive
autoimmun
differ
tcell
specif
antigen
respons
patient
uveiti
due
epitop
spread
respond
one
peptid
ie
sever
epitop
recogn
patient
anim
eau
tend
respond
incit
antigen
common
pattern
lymphocyt
respons
clinic
studi
report
far
earli
clinic
studi
humor
respons
show
presenc
antiretin
autoantibodi
includ
antisantigen
antibodi
sera
uveiti
patient
fig
good
correl
presenc
level
autoantibodi
clinic
diseas
moreov
antiirbp
antibodi
report
occur
frequenc
sera
patient
uveiti
normal
control
differ
stronger
affin
antibodi
patient
uveiti
relationship
humor
cellular
respons
autoantigen
studi
group
patient
endogen
uveiti
birdshot
retinochoroidopathi
retin
vascul
diseas
antibodi
titer
santigen
irbp
found
decreas
activ
inflamm
period
lymphocyt
respons
santigen
found
signific
period
preced
relaps
ocular
inflamm
support
pathogen
role
lymphocyt
retin
autoimmun
role
humor
cellular
respons
retin
autoantigen
remain
unclear
possibl
differ
subset
patient
uveiti
genet
determin
respond
differ
epitop
antigen
result
wide
spectrum
clinic
diseas
encount
retin
autoimmun
may
alway
pathogen
studi
central
nervou
system
cn
injuri
repar
process
reveal
possibl
benefici
role
autoimmun
limit
selfinjuri
insult
cn
axon
injuri
histon
peptid
certain
viral
agent
molecular
mimicri
also
suspect
play
role
confer
diseas
suscept
patient
certain
hla
haplotyp
like
hla
acut
anterior
uveiti
hla
diseas
birdshot
retinochoroidopathi
synthet
peptid
deriv
hlab
molecul
amino
acid
sequenc
homolog
santigen
report
induc
eau
anim
lymphocyt
patient
uveiti
especi
diseas
respond
peptid
deriv
hlab
molecul
peptid
deriv
santigen
demonstr
possibl
immunolog
mimicri
addit
studi
also
show
sequenc
homolog
peptid
rotaviru
casein
protein
protein
found
milk
crossreact
cellular
immun
peptid
found
anim
studi
togeth
studi
bring
forward
possibl
immunolog
mimicri
exogen
factor
like
infect
foreign
protein
break
toler
induc
autoimmun
guardian
prevent
patholog
autoimmun
immun
toler
immun
toler
usual
maintain
mechan
describ
earlier
could
lost
modul
demonstr
studi
show
heat
shock
protein
hsp
modul
apc
function
result
loss
toler
anim
model
hsp
especi
microbi
implic
pathogenesi
diseas
demonstr
induc
inflamm
eye
anim
studi
therefor
one
may
specul
infect
subsequ
releas
microbi
hsp
could
initi
trigger
event
result
chang
apc
function
subsequ
loss
toler
lead
autoimmun
notion
remain
hypothes
uveiti
sinc
heterogen
diseas
evid
initi
trigger
event
usual
difficult
identifi
due
protract
cours
delay
trigger
diseas
present
furthermor
diseas
could
multipl
trigger
mechan
differ
trigger
may
lead
diseas
make
clinic
data
difficult
interpret
retin
autoimmun
may
physiolog
process
rather
patholog
one
given
role
organand
tissuespecif
protect
damag
injuri
stress
normal
retina
may
account
evid
retin
autoimmun
detect
normal
subject
still
much
unknown
regul
mainten
fine
balanc
protect
destruct
given
paradox
role
resid
group
cell
rapid
technolog
advanc
molecular
immunolog
new
tool
unravel
role
retina
autoimmun
physiolog
patholog
state
eye
avail
novel
target
therapeut
strategi
could
develop
manag
retin
autoimmunityinduc
diseas
near
futur
